Next Article in Journal
7-Geranyloxycinnamic Acid Isolated from Melicope lunu-ankenda Leaves Perturbs Colon Cancer and Breast Cancer Cell Lines’ Growth via Induction of Apoptotic Pathway
Next Article in Special Issue
Optimization of the Composition of Mesoporous Polymer–Ceramic Nanocomposite Granules for Bone Regeneration
Previous Article in Journal
The Research Progress of Extraction, Purification and Analysis Methods of Phenolic Compounds from Blueberry: A Comprehensive Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Monocyte Differentiation on Atomic Layer-Deposited (ALD) Hydroxyapatite Coating on Titanium Substrate

1
Department of Anatomy and Cell Biology, Institute of Cancer Research and Translational Medicine, Medical Research Center, University of Oulu, P.O. Box 5000, 90014 Oulu, Finland
2
Department of Prosthetic Dentistry and Stomatognathic Physiology, Institute of Dentistry, University of Turku, 20520 Turku, Finland
3
Department of Chemistry, University of Helsinki, P.O. Box 55, 00014 Helsinki, Finland
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(8), 3611; https://doi.org/10.3390/molecules28083611
Submission received: 21 February 2023 / Revised: 13 April 2023 / Accepted: 19 April 2023 / Published: 21 April 2023
(This article belongs to the Special Issue Biomaterials Based on Calcium Phosphates and Their Modifications)

Abstract

:
Hydroxyapatite (HA; Ca10(PO4)6(OH)2) coating of bone implants has many beneficial properties as it improves osseointegration and eventually becomes degraded and replaced with new bone. We prepared HA coating on a titanium substrate with atomic layer deposition (ALD) and compared monocyte differentiation and material resorption between ALD-HA and bone. After stimulation with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-B ligand (RANKL), human peripheral blood monocytes differentiated into resorbing osteoclasts on bovine bone, but non-resorbing foreign body cells were observed on ALD-HA. The analysis of the topography of ALD-HA and bone showed no differences in wettability (water contact angle on ALD-HA 86.2° vs. 86.7° on the bone), but the surface roughness of ALD-HA (Ra 0.713 µm) was significantly lower compared to bone (Ra 2.30 µm). The cellular reaction observed on ALD-HA might be a consequence of the topographical properties of the coating. The absence of resorptive osteoclasts on ALD-HA might indicate inhibition of their differentiation or the need to modify the coating to induce osteoclast differentiation.

Graphical Abstract

1. Introduction

Besides the ancient efforts to replace missing teeth and repair injured tissues and the progression to the first documented use of a metal implant in 1565, it was not until the beginning of the 20th century that implants became a vastly used treatment for tissue replacement. During the last century, several types of metals, polymers, and ceramics with various coatings and surface modifications have been developed in an attempt to meet the increasing demand for implantable devices [1].
Orthopedic implants are one of the most common synthetic devices for tissue engineering [2]. The properties of an ideal bone biomaterial have been described by Bose et al. [3], including biocompatibility, suitable mechanical properties, porosity, and resorbability. Concerning biocompatibility in bone tissue, the terms osteoconductive and osteoinductive have been used to describe the necessary bone cell adhesion, proliferation, and bone ingrowth, as well as the promotion of new bone formation by immature cell differentiation and osteogenesis, respectively [3,4]. Together, osteoconduction and osteoinduction lead to osseointegration, described as a direct contact between living bone and the implant [5]. Failed osseointegration is the main reason for implant failure, often leading to implant loosening and the need for revision surgery. This causes a burden for the patients and the whole healthcare system and increases the total costs of orthopedic treatment [6,7,8,9].
The natural bone and teeth mineral hydroxyapatite (HA; Ca10(PO4)6(OH)2) has been utilized in bone implant coating since it can improve osseointegration [10,11,12,13,14,15]. The stable fixation of the implant is based on the direct growth of bone tissue into the HA coating [14,16,17], the subsequent degradation of HA, and the final replacement by new bone [18,19,20,21]. The bone degradation phase is conducted by the special multinuclear bone cells, osteoclasts, which are also active during normal bone homeostasis. The complex bone microarchitecture is sustained and renewed by the cooperation of the bone-resorbing osteoclasts, bone-forming osteoblasts, and mechanosensing osteocytes [22]. This activity, termed remodeling, also occurs at the bone-HA interface and is a crucial process for implant fixation into bone tissue [18,20,23,24,25,26,27,28,29].
Upon implantation of a foreign material in the body, a foreign-body reaction begins around the implant. The reaction includes the migration of mononuclear cells at the implantation site and their differentiation into multinuclear macrophages, also termed foreign body giant cells (FBGC), which try to phagocytose the foreign material or degrade it by secreting reactive oxygen species (ROS) and matrix metalloproteases (MMPs) [30,31]. FBGCs cells bear a resemblance to the bone-resorbing osteoclasts, except that the FBGCs are larger and cannot resorb bone tissue [31,32,33,34]. However, the foreign body cells can produce cytokines and other mediators promoting osteoclastogenesis [35,36,37], or they can directly differentiate into functional osteoclasts [38,39]. This leads to increased bone resorption and osteolysis around the implant, a common reason for implant loosening.
Considering HA, several studies have shown that FBGCs are induced by HA-particle stimulation [40,41,42,43] and that the HA-induced FBGCs from mouse subcutaneous tissue can differentiate into osteoclasts [44]. Furthermore, although FBGCs do not resorb bone, they have been shown to dissolve HA-like calcium phosphate coating [32].
Osteoclasts can resorb HA [18,19,21,25,32,45,46], but there are also contrary results showing no resorption on pure HA [47,48]. The contradictory results can be explained by the studies, which suggested that the surface topography of the HA coating has major consequences on osteoclast differentiation and function [49,50,51,52,53,54,55] and that increasing the HA content in calcium phosphate materials inhibits osteoclastogenesis [56]. In fact, the implant chemistry and topography affect the whole initial foreign body reaction and the complex cellular interactions thereafter [57,58,59,60].
A variety of methods have been utilized to synthesize calcium phosphate coatings. Examples include sol-gel, plasma spraying, laser ablation, electrophoretic deposition, and sputter coating, but all these methods have been found to have challenges concerning the phase or the stability of the coatings. With plasma spraying and electrophoretic deposition, the most common problems are cracking and flaking of the coatings, which are obviously a non-wanted property concerning implantable devices intended to survive years inside the body. Furthermore, laser ablation and sol-gel techniques are expensive, whereas high temperatures are required for plasma spraying, laser ablation, and electrophoretic deposition [61,62,63].
Atomic layer deposition (ALD) is a method that has many beneficial properties in contrast to the other methods described above. For instance, ALD can be used for coating complex three-dimensional surfaces on a nanometer scale, and the coating thickness can be controlled in detail, leading to very uniform and conformal coatings [64,65].
We have previously described the preparation of a nanocrystalline HA coating on Ti substrate by converting ALD-CaCO3 to HA by chemical treatment in a dilute phosphate solution [66]. We have also shown that the coating is intact [67] and suitable for cell culture, as osteoblast line cells attached to the coating, and the cell viability was normal [68]. Further, we have also successfully cultured human bone marrow-derived cells on the coating [66]. However, we have not previously characterized the foreign body reaction or osteoclast actions on the coating. To our knowledge, this is the first study of the cellular reactions occurring on the ALD-HA coating when monocytes come into contact with it. We hypothesized that a foreign body reaction follows, with the possible subsequent resorption of the coating. A resorbable coating could offer new insights for developing implant materials with improved osseointegration properties since most of the bone remodeling takes place at previously resorbed surfaces [22]. Previous studies have utilized different methods in producing the HA coating, but the coating produced by the ALD method utilized in this study has not been characterized before in regard to monocyte differentiation and resorbability. This is the first study of ALD-HA coating and primary human monocyte culture with 14 days culture period, which is considerably longer than the previously studied initial cellular reactions performed mostly with cell lines.

2. Results

2.1. Contact Angle and Surface Roughness Measurements

The contact angle and surface roughness (Ra) values are shown in Table 1. The non-coated Ti sample, ALD-HA, and bovine bone slice showed similar hydrophilic contact angle values. However, the ALD-HA surfaces demonstrated significantly lower surface roughness (Ra 0.713 µm) compared to the bovine bone slice (Ra 2.30 µm; p < 0.001). The surface roughness of the non-coated Ti sample was 1.21 µm, which is between the values of ALD-HA and bone and differs from both (p < 0.001). The ALD-HA coating, therefore, smoothens the surface of the Ti sample. Figure 1 displays the surface of the non-coated Ti sample and ALD-HA. HA crystals can be seen on ALD-HA, whereas the non-coated sample is devoid of crystals. Figure 2 displays the 3D surface profiles of non-coated Ti sample, ALD-HA, and bovine bone slices. Note that the 0.713 µm roughness is much more than the HA film thickness (380 nm).

2.2. Multinuclear Foreign Body Cells Generated on ALD-HA

We have previously studied osteoclast formation from peripheral blood monocytes on bone [69]. During the 14 days culture, stimulated with the growth factors RANKL and M-CSF, the monocytes undergo differentiation into multinuclear bone-resorbing osteoclasts. This setup was used as a control in this study. The multinuclear cells on the bone surface with actin rings are shown in Figure 3A, and the resorption pits imaged with FESEM are shown in Figure 3C. When monocytes were cultured on ALD-HA with the osteoclastogenic growth factors, large multinuclear cells were observed in the samples (Figure 3B). The actin rings in multinuclear cells on bone were bright and thick, whereas, on ALD-HA, the rings were paler and more diffuse. Our previous study [69] shows that the average nuclei number in human osteoclasts differentiated from peripheral blood monocytes is 4. In this study, we did not analyze the nuclei number due to the limited number of samples. Still, the confocal microscopy images show that the nuclei number of multinuclear cells on the ALD-HA surface is substantially larger than on bone. In addition, the FESEM images show the large flat multinuclear cells covering the ALD-HA surfaces uniformly, whereas, on bone, only occasional, smaller osteoclasts are observed in or near the resorption pits. The total lack of resorption pits on ALD-HA suggests that the multinuclear cells on ALD-HA are foreign body cells instead of osteoclasts.

3. Discussion

We have previously demonstrated osteoblast lineage cell adhesion on the ALD-HA surface with focal adhesion-like structures [68]. The purpose of this work was to continue cell adhesion studies with monocytes and to investigate whether osteoclastogenesis or foreign body reaction follows the cell attachment. To our knowledge, these important cellular reactions have not been previously studied on ALD-HA. Our results show that peripheral blood monocytes undergo differentiation into bone-resorbing osteoclasts on the bone surface, but on the ALD-HA coating, the monocytes differentiate into foreign body cells without the capacity to resorb the coating. Similar results were obtained in our previous study, where human bone marrow mononuclear cells were cultured on bone and ALD-HA and differentiated into multinuclear cells [66]. Other studies have also observed the large, flat morphology of the multinuclear cells cultured on HA [45,52]. Comparable morphology was also present in studies where large multinuclear cells appeared on nacre [70] or HA [46,71], compared to smaller osteoclasts on bone. Chappard et al. [70] described the properties of different types of giant cells and suggested that a certain type of giant cell is induced on biomaterials. This giant cell has a nonuniform distribution of nuclei, and their differentiation is not associated with inflammation. In addition to HA and nacre, various other biomaterials have been shown to induce different types of giant cells. Their morphology and characteristics were reviewed by Al-Maawi et al. [72]. In our samples, the multinuclear cells on ALD-HA had a fairly central location of the nuclei, but also a few Touton cell-like (crown-resembling central organization of nuclei) and Langhans cell-like (horseshoe-resembling organization of nuclei) giant cells were observed. Therefore, it is possible that several different types of giant cells are induced on our ALD-HA coating.
Considering biomaterial degradation by multinuclear cells, Ghanaati et al. [73] demonstrated faster degradation of beta-tricalcium phosphate (β-TCP) granules compared to HA granules implanted into goat muscle tissue. In their study, HA granules remained intact in the implanted tissue for a longer time compared to β-TCP, but eventually, HA granules started to show dissolution by multinuclear cells. In addition, the multinuclear cells induced with β-TCP presented a more intense TRACP-staining, probably depicting their increased degradation ability compared to cells on HA granules. Although the multinuclear cell types in their study were not specifically identified as foreign body cells or osteoclasts, it is possible that β-TCP induced resorptive osteoclasts, but HA induced foreign body cells with limited dissolution capacity. This would be in line with our results concerning the multinuclear cells on bone and HA. In addition, the slow degradation process of implanted HA materials has also been noted by Okuda et al. [74] Therefore, it is possible that our 14 days cell culture period was sufficient to induce the initial foreign body reaction, but not the possible subsequent osteoclastogenesis and resorption of the material, as described by Sabokbar et al. [44]. Furthermore, we could not detect any dissolution of the ALD-HA surface by the multinuclear cells, contrary to a study by ten Harkel et al. [32], which demonstrated that although not capable of bone resorption, the FBGCs dissolved HA-like calcium phosphate coating. However, even when human peripheral blood monocytes were differentiated into osteoclasts and cultured for 21 days by Ciapetti et al. [54], no resorption pits were observed on biomimetic HA coatings. In contrast, resorption was evident on stoichiometric sintered HA, which is additional proof of the major effects the surface topography has on osteoclast fusion and activity, also observed in other studies [53,54,55,75,76,77,78,79].
Surface wettability can be estimated by measuring the CA, which represents the angle between the tangent line to a drop surface of the liquid at the three-phase boundary and the horizontal surface of the solid interface. Generally, the water CA ranges from 0 to 180° and is considered hydrophilic at a value lower than 90° and hydrophobic when the value is more than 90°. CA values close to 0° are regarded as superhydrophilic, whereas above 150 are regarded as superhydrophobic [80]. In our study, the CA values were 86.9 (3.2), 86.2 (4.5), and 86.7 (4.5) for the non-coated Ti sample, ALD-HA, and bovine bone slice, respectively, indicating slightly hydrophilic surfaces for all investigated materials. Surface chemistry plays an essential role in determining wettability, as indicated in a study by Surmeneva et al. [81]. Their study showed that the deposition of a nano-HA film onto the titanium surface led to a decrease in the water contact angle from 130 ± 5° to 50 ± 5°. Additionally, the surface topography and roughness can affect wettability. However, similar wettability behavior was observed for the ALD-HA and bovine bone slice surfaces despite the significant difference in roughness values of (0.713 µm) and (2.30 µm), respectively. ALD-HA coating of the titanium surface used in this study decreased the surface roughness from 1.21 (±0.05) to 0.713 (±0.08) µm.
Studies have shown that the implant surface topography and chemical composition impact osteoclast activity [53,54,55,75,76,77,78,79]. In general, rough surfaces promote increased osteoclastogenesis compared to smooth surfaces [75,76,77,78]. The same applies to calcium phosphate coatings as well. However, considering osteoclastogenesis and osteoclast activity, there seems to be a window for the optimal surface architecture since submicron-scale (≤1 µm) coatings were found more favorable compared to micron-size (≥1 µm) [50,52,82,83,84] or nanoscale (1–100 nm) coatings [49,51,85]. This could explain the contradictory results about the capacity of osteoclasts to resorb the HA coating [18,19,21,25,32,45,47,48]. Considering our results, it is possible that some of the multinuclear cells on ALD-HA are osteoclasts, but the surface topography of our samples does not support resorption, although the Ra value of ALD-HA (0.713 µm) is in the optimal range. In fact, the actin rings we observed in the cells on ALD-HA very much resembled the ones that Costa et al. [52] described as the characteristics of non-resorbing cells since the rings are more diffuse and paler compared to the thick and bright structures observed in osteoclasts on bone. It seems that the rougher surface of the bone (Ra 2.300 µm) supports osteoclastogenesis and resorption, but the topography of the ALD-HA surface does not induce the same reaction from peripheral blood monocytes in our study. In addition to the topographical and chemical differences between the bone and ALD-HA surfaces, it is of note that several other factors, such as pH and the ions released from the surface can have a major impact on the cellular reactions, as reviewed recently [86]. This especially concerns osteoclasts, as they are also in vivo regulated by H+, Ca2+, and PO43− ions, which are the components of both bone and HA and might be released from these materials in different amounts [54].
Although the foreign body reaction, including the differentiation of multinuclear FBGs and osteoclasts, is often thought to be the unwanted process leading to implant loosening, different perspectives consider these events natural and crucial for osseointegration. Trindade et al. [87] discussed these events in a recent review and expressed an opinion of osseointegration being a consequence of the foreign body reaction, upon the condition that the cellular responses are tightly controlled and in equilibrium, without excess differentiation of multinuclear cells and the following osteolysis. Furthermore, considering ALD coatings, Smieszek et al. [88] observed increased viability and activity of osteoblast lineage MC3T3 cells on ALD TiO2 coating, but osteoclast activity on the coating was decreased. We obtained previously similar results with MC3T3 osteoblasts on ALD-HA [68]. It is possible that the observation of Smieszek et al. on the inhibited preosteoclast invasion on the ALD TiO2 coating could also explain our results in this present study. Although the observation in the study by Smieszek et al. considered a co-culture of MC3T3 osteoblasts and preosteoclasts, it is of note that peripheral blood contains small amounts of mesenchymal stem/stromal cells [89,90], which might behave in a similar way to osteoblast lineage cells on the ALD coating, i.e., prevent the attachment of osteoclast lineage cells. The mesenchymal stromal cells are osteoblast precursors, which regulate osteoclastogenesis [91,92] and could be the mediators behind the effects observed in this study. If these cells attach firmly to the smoother ALD coating, they prevent preosteoclast attachment, and further, their altered metabolic activity favors FBGC differentiation instead of osteoclasts. As Smieszek et al. discussed, this is beneficial for osseointegration since excess osteoclast activity is inhibited. However, these explanations concerning this study are hypothetical and require further investigation, but nevertheless offer an interesting approach for studying the initial cellular reactions on ALD-produced coatings, which, at present, are mainly unknown. Moreover, as Ciapetti et al. [54] and He et al. [55] noted, the optimal biomaterial surface should support all types of cells in contact with it, such as osteoblasts, osteoclasts, and macrophages, but the properties of different materials might not be beneficial for all these cells at the same time. Therefore, further studies, including co-cultures with all types of bone cells, are required, especially as recent studies have focused mainly on one cell type at a time, which does not represent the complex situation in vivo.

4. Materials and Methods

4.1. Preparation of Nanocrystalline HA Coating (ALD-HA) on Ti Substrates with ALD Method

The HA coatings were fabricated on Ti substrates as described by Avila et al. and Holopainen et al. [66,67]. The substrate for ALD-HA coating was a 5 cm × 5 cm (25 cm2), 1 mm thick titanium sheet (Grade 2, ASTM B265 specification, William Gregor Ltd., London, UK). The ALD coating was started by depositing a thin film of CaCO3 in an F-120 ALD reactor (ASM Microchemistry Ltd., Helsinki, Finland) with nitrogen carrier and purging gas. The CaCO3 films were deposited using the Ca(thd)2—O3 process previously reported in the literature [93]. Ca(thd)2 (Volatec Oy, Vantaa, Finland) was evaporated at 188 °C, and O3 was generated from O2 (99.9999%) with a Wedeco Ozomatic Modular 4 HC Lab ozone generator. Samples were produced with 4000 ALD cycles resulting in a thickness of 380 nm. Pulses and purges of 1 s were used for all precursors. The depositions were conducted at 250 °C. Conversion of CaCO3 to HA was achieved by using 0.2 M (NH4)2HPO4 (99%; Merck KGaA, Darmstadt, Germany) solution at 95 °C. After conversion, the samples were rinsed with deionized water and blown dry with compressed air. A manual plate cutter (Bernardo PTS 1050 S Manual disc cutter, Linz, Austria) was used for cutting the ALD-coated titanium plates. The Ti plate was firmly placed in a disc pressing to keep it in place during the cutting process. The plate was cut to produce 1 cm2 square-shaped size discs. Before cell culture, the samples were soaked in 70% ethanol for 10 min and air-dried.

4.2. Contact Angle and Surface Roughness Measurements

The surface contact angle (CA), which represents surface wettability, of ALD-HA and bovine bone slice were evaluated using the sessile drop method described by Jong et al. [94]. An Optical tensiometer (Theta, Biolin Scientific Oy, Espoo, Finland) was used for water CA measurements. Five randomly selected points per sample were evaluated. For each droplet, 120 images were recorded in 20 s. The Young–Laplace equation was used to define the CA around the droplet. The surface roughness averages (Ra) of ALD-HA and the bovine bone specimens were measured using a 3D non-contact optical profilometer (Bruker Nano GmbH, Billerica, MA, USA). A total of 5 randomly selected points per sample were evaluated with a 5× objective lens and a 0.5 multiplier, using a back scan and length parameters of 20 μm and 60 μm in VSI/VXI mode to obtain a 3D image of the specimen surfaces. Software (Vision 64) was used to generate surface areas and roughness parameters.

4.3. Monocyte Differentiation on Bone and ALD-HA

The isolation and culture protocol for peripheral blood monocytes were modified from [95]. The cells were collected from whole blood samples from 3 healthy female donors aged between 39–45 years, who provided informed consent. The study was approved by the Ethical Committee of The Northern Ostrobothnia Hospital District (Oulu University Hospital EETTMK: 180 and 191/2001; 12/2004; 35/2009; 29/2011). Blood was diluted 1:1 in PBS and layered over Ficoll-Paque Premium solution (GE Healthcare, Little Chalfont, UK). The samples were centrifuged at 400× g for 35 min following the manufacturer’s protocol. Mononuclear cell layer was collected and centrifuged twice at 190× g for 10 min in PBS and finally suspended in α-MEM (Corning Life Sciences) containing 10% FBS (Biowest, Riverside, MO, USA), 100 IU/mL penicillin, and 100 µg/mL streptomycin (Sigma-Aldrich, St. Louis, MO, USA). A total of 300 000 cells (9.4 × 105 cells/cm2) were layered on sonicated bovine cortical bone slices (0.28 cm2; Lehenkari Consulting, Oulu, Finland) in 96-well plates (Cellstar; Greiner Bio-One, Kremsmünster, Austria) in a final volume of 200 µL. Then, 2 × 106 cells (1.05 × 106 cells/cm2) were layered on ALD-HA samples (1 cm2) in 24-well plates (Cellstar; Greiner Bio-One) in a final volume of 1 mL. Osteoclastogenesis was induced with 20 ng/mL RANKL (PeproTech EC, London, UK) and 10 ng/mL M-CSF (R&D Systems, Minneapolis, MN, USA). Half of the media was changed every 3–4 days (100 µL/well for bone slices and 500 µL/well for ALD-HA). At 1-week time point, all media was changed (200 μL/well for bone slices and 1 mL/well for ALD-HA). Cells were cultured at +37 °C (5% CO2, 95% air) for 14 days.

4.4. Confocal Microscopy

The cells were fixed with 4% paraformaldehyde (PFA) in PBS for 10 min. The actin cytoskeleton was stained with Alexa 488-conjugated phalloidin (200 U/mL stock diluted 1:100 in PBS; Invitrogen Europe, Paisley, UK) for 20 min at +37 °C. Nuclei were stained with Hoechst 33258 (1 mg/mL stock diluted 1:800 in PBS; Sigma-Aldrich) for 10 min at RT. The samples were mounted in 70% glycerol-PBS. The cells were viewed with Leica TCS SP8 confocal with a DMI8 microscope using LAS X 3.5.2 acquisition software. The used objective was an HC PL APO CS2 CS2 20 × 0.75 DRY. Samples were imaged with 488 nm and 405 nm solid-state lasers; the pinhole was set to Airy 1 and scan speed to 600 Hz. Maximum intensity projections (MIP) were created from the Z-stacks.

4.5. Field Emission Scanning Electron Microscopy (FESEM)

The bone slices, non-coated Ti samples, and ALD-HA samples were dehydrated in ascending ethanol series and dried with a critical point drying equipment K850 (Quorum Technologies, Lewes, UK). Samples were coated with 5 nm platinum by Q150T ES sputter coater (Quorum Technologies, Lewes, UK) and viewed with Sigma HD VP FE-SEM (Carl Zeiss Microscopy GmbH, Oberkochen, Germany). FESEM images were taken with 5.0 kV voltage.

5. Conclusions

We demonstrated for the first time that human peripheral blood monocyte differentiation on bone and ALD-HA leads to different outcomes, as on bone osteoclastogenesis is induced, but on ALD-HA, a foreign body reaction is observed. On bone slices, the small multinuclear cells were able to resorb the substrate generating typical osteoclastic resorption pits. In contrast, on ALD-HA, the multinuclear cells were remarkably large with several nuclei but lacked the resorption capacity of the surface. We did not detect differences in the surface wettability between bone and ALD-HA, and both surfaces were found to be hydrophilic. The surface roughness, however, was found to be greater on bone, which might support osteoclastogenesis, compared to the smoother surface in the ALD-HA samples. These results provide knowledge about the initial cellular reactions of ALD-HA, which is of great importance when developing new types of implant surfaces with modern methods. With the modifications of this technique, new types of nanothin coatings can be produced for orthopedic and dental implants with conformal and porous surfaces.

Author Contributions

Conceptualization, E.K. and J.T. Methodology, E.K., F.A., and J.T. Validation, E.K., F.A., and J.T. Formal analysis, E.K. and F.A. Investigation, E.K. and F.A. Resources, E.K. and F.A. Data curation, E.K. and F.A. Writing—original draft preparation, E.K., F.A., and J.T. Writing—Review and editing, E.K., F.A., J.H., M.R., and J.T. Visualization, E.K. and F.A. Supervision, J.T. Project administration, J.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethical Committee of The Northern Ostrobothnia Hospital District (Oulu University hospital [EETTMK: 180 and 191/2001; 12/2004; 35/2009; 29/2011]).

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

The data presented in this study are available in the article.

Acknowledgments

Open access funding provided by University of Helsinki. Biocenter Oulu Light Microscopy Core Facility and Biocenter Oulu Electron Microscopy Core Facility, University of Oulu, supported by Biocenter, Finland, is acknowledged for their assistance with confocal and electron microscopic analysis.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not applicable.

References

  1. Balamurugan, A.; Rajeswari, S.; Balossier, G.; Rebelo, A.H.S.; Ferreira, J.M.F. Corrosion Aspects of Metallic Implants—An Overview. Mater. Corros. 2008, 59, 855–869. [Google Scholar] [CrossRef]
  2. Cheng, C.K.; Wang, X.H.; Luan, Y.C.; Zhang, N.Z.; Liu, B.L.; Ma, X.Y.; Nie, M.D. Challenges of Pre-Clinical Testing in Orthopedic Implant Development. Med. Eng. Phys. 2019, 72, 49–54. [Google Scholar] [CrossRef] [PubMed]
  3. Bose, S.; Roy, M.; Bandyopadhyay, A. Recent Advances in Bone Tissue Engineering Scaffolds. Trends Biotechnol. 2012, 30, 546–554. [Google Scholar] [CrossRef]
  4. Albrektsson, T.; Johansson, C. Osteoinduction, Osteoconduction and Osseointegration. Eur. Spine J. 2001, 10 (Suppl. 2), S96–S101. [Google Scholar] [CrossRef] [PubMed]
  5. Albrektsson, T.; Brånemark, P.I.; Hansson, H.A.; Lindström, J. Osseointegrated Titanium Implants. Requirements for Ensuring a Long-Lasting, Direct Bone-to-Implant Anchorage in Man. Acta Orthop. Scand. 1981, 52, 155–170. [Google Scholar] [CrossRef]
  6. Bozic, K.J.; Kurtz, S.M.; Lau, E.; Ong, K.; Chiu, V.; Vail, T.P.; Rubash, H.E.; Berry, D.J. The Epidemiology of Revision Total Knee Arthroplasty in the United States. Clin. Orthop. Relat. Res. 2010, 468, 45. [Google Scholar] [CrossRef]
  7. Bozic, K.J.; Kurtz, S.M.; Lau, E.; Ong, K.; Vail, D.T.P.; Berry, D.J. The Epidemiology of Revision Total Hip Arthroplasty in the United States. J. Bone Jt. Surg. 2009, 91, 128–133. [Google Scholar] [CrossRef]
  8. Nobles, K.P.; Janorkar, A.V.; Williamson, R.S. Surface Modifications to Enhance Osseointegration–Resulting Material Properties and Biological Responses. J. Biomed. Mater. Res. B Appl. Biomater. 2021, 109, 1909–1923. [Google Scholar] [CrossRef]
  9. Schroer, W.C.; Berend, K.R.; Lombardi, A.V.; Barnes, C.L.; Bolognesi, M.P.; Berend, M.E.; Ritter, M.A.; Nunley, R.M. Why Are Total Knees Failing Today? Etiology of Total Knee Revision in 2010 and 2011. J. Arthroplast. 2013, 28, 116–119. [Google Scholar] [CrossRef]
  10. Kaur, M.; Singh, K. Review on Titanium and Titanium Based Alloys as Biomaterials for Orthopaedic Applications. Mater. Sci. Eng. C 2019, 102, 844–862. [Google Scholar] [CrossRef]
  11. Liu, X.; Chu, P.K.; Ding, C. Surface Modification of Titanium, Titanium Alloys, and Related Materials for Biomedical Applications. Mater. Sci. Eng. R Rep. 2004, 47, 49–121. [Google Scholar] [CrossRef]
  12. Hao, J.; Kuroda, S.; Ohya, K.; Bartakova, S.; Aoki, H.; Kasugai, S. Enhanced Osteoblast and Osteoclast Responses to a Thin Film Sputtered Hydroxyapatite Coating. J. Mater. Sci. Mater. Med. 2011, 22, 1489–1499. [Google Scholar] [CrossRef]
  13. Landor, I.; Vavrik, P.; Sosna, A.; Jahoda, D.; Hahn, H.; Daniel, M. Hydroxyapatite Porous Coating and the Osteointegration of the Total Hip Replacement. Arch. Orthop. Trauma Surg. 2007, 127, 81–89. [Google Scholar] [CrossRef]
  14. Wang, H.; Eliaz, N.; Xiang, Z.; Hsu, H.P.; Spector, M.; Hobbs, L.W. Early Bone Apposition in Vivo on Plasma-Sprayed and Electrochemically Deposited Hydroxyapatite Coatings on Titanium Alloy. Biomaterials 2006, 27, 4192–4203. [Google Scholar] [CrossRef]
  15. Coathup, M.J.; Blunn, G.W.; Flynn, N.; Williams, C.; Thomas, N.P. A Comparison of Bone Remodelling around Hydroxyapatite-Coated, Porous-Coated and Grit-Blasted Hip Replacements Retrieved at Post-Mortem. J. Bone Jt. Surg. Br. 2001, 83, 118–123. [Google Scholar] [CrossRef]
  16. Daugaard, H.; Elmengaard, B.; Bechtold, J.E.; Jensen, T.; Soballe, K. The Effect on Bone Growth Enhancement of Implant Coatings with Hydroxyapatite and Collagen Deposited Electrochemically and by Plasma Spray. J. Biomed. Mater. Res. A 2010, 92, 913–921. [Google Scholar] [CrossRef]
  17. Porter, A.E.; Hobbs, L.W.; Rosen, V.B.; Spector, M. The Ultrastructure of the Plasma-Sprayed Hydroxyapatite–Bone Interface Predisposing to Bone Bonding. Biomaterials 2002, 23, 725–733. [Google Scholar] [CrossRef]
  18. Aebli, N.; Krebs, J.; Schwenke, D.; Stich, H.; Schwalder, P.; Theis, J.C. Degradation of Hydroxyapatite Coating on a Well-Functioning Femoral Component. J. Bone Jt. Surg. Ser. B 2003, 85, 499–503. [Google Scholar] [CrossRef]
  19. Overgaard, S.; Lind, M.; Josephsen, K.; Maunsbach, A.B.; Bünger, C.; Søballe, K. Resorption of Hydroxyapatite and Fluorapatite Ceramic Coatings on Weight-Bearing Implants: A Quantitative and Morphological Study in Dogs. J. Biomed. Mater. Res. 1998, 39, 141–152. [Google Scholar] [CrossRef]
  20. Tonino, A.J.; Thèrin, M.; Doyle, C. Hydroxyapatite-Coated Femoral Stems. Histology and Histomorphometry around Five Components Retrieved at Post Mortem. J. Bone Jt. Surg. Br. 1999, 81, 148–154. [Google Scholar] [CrossRef]
  21. Tonino, A.; van der Wal, B.; Heyligers, I.; Grimm, B. Bone Remodeling and Hydroxyapatite Resorption in Coated Primary Hip Prostheses. Clin. Orthop. Relat. Res. 2009, 467, 478–484. [Google Scholar] [CrossRef] [PubMed]
  22. Bolamperti, S.; Villa, I.; Rubinacci, A. Bone Remodeling: An Operational Process Ensuring Survival and Bone Mechanical Competence. Bone Res. 2022, 10, 48. [Google Scholar] [CrossRef] [PubMed]
  23. Yang, B.C.; Lee, J.W.; Ju, C.P.; Lin, J.H.C. Physical/Chemical Properties and Resorption Behavior of a Newly Developed Ca/P/S-Based Bone Substitute Material. Materials 2020, 13, 3458. [Google Scholar] [CrossRef] [PubMed]
  24. Haga, M.; Fujii, N.; Nozawa-Inoue, K.; Nomura, S.; Oda, K.; Uoshima, K.; Maeda, T. Detailed Process of Bone Remodeling after Achievement of Osseointegration in a Rat Implantation Model. Anat. Rec. 2009, 292, 38–47. [Google Scholar] [CrossRef]
  25. Wenisch, S.; Stahl, J.-P.; Horas, U.; Heiss, C.; Kilian, O.; Trinkaus, K.; Hild, A.; Schnettler, R. In Vivo Mechanisms of Hydroxyapatite Ceramic Degradation by Osteoclasts: Fine Structural Microscopy. J. Biomed. Mater. Res. A 2003, 67, 713–718. [Google Scholar] [CrossRef]
  26. Akiyama, N.; Takemoto, M.; Fujibayashi, S.; Neo, M.; Hirano, M.; Nakamura, T. Difference between Dogs and Rats with Regard to Osteoclast-like Cells in Calcium-Deficient Hydroxyapatite-Induced Osteoinduction. J. Biomed. Mater. Res. A 2011, 96A, 402–412. [Google Scholar] [CrossRef]
  27. Kondo, N.; Ogose, A.; Tokunaga, K.; Umezu, H.; Arai, K.; Kudo, N.; Hoshino, M.; Inoue, H.; Irie, H.; Kuroda, K.; et al. Osteoinduction with Highly Purified β-Tricalcium Phosphate in Dog Dorsal Muscles and the Proliferation of Osteoclasts before Heterotopic Bone Formation. Biomaterials 2006, 27, 4419–4427. [Google Scholar] [CrossRef]
  28. Nasu, T.; Takemoto, M.; Akiyama, N.; Fujibayashi, S.; Neo, M.; Nakamura, T. EP4 Agonist Accelerates Osteoinduction and Degradation of P-Tricalcium Phosphate by Stimulating Osteoclastogenesis. J. Biomed. Mater. Res. A 2009, 89, 601–608. [Google Scholar] [CrossRef]
  29. Davison, N.L.; Gamblin, A.L.; Layrolle, P.; Yuan, H.; de Bruijn, J.D.; Barrère-de Groot, F. Liposomal Clodronate Inhibition of Osteoclastogenesis and Osteoinduction by Submicrostructured Beta-Tricalcium Phosphate. Biomaterials 2014, 35, 5088–5097. [Google Scholar] [CrossRef]
  30. Chandorkar, Y.; Ravikumar, K.; Basu, B. The Foreign Body Response Demystified. ACS Biomater. Sci. Eng. 2019, 5, 19–44. [Google Scholar] [CrossRef]
  31. Ahmadzadeh, K.; Vanoppen, M.; Rose, C.D.; Matthys, P.; Wouters, C.H. Multinucleated Giant Cells: Current Insights in Phenotype, Biological Activities, and Mechanism of Formation. Front. Cell Dev. Biol. 2022, 10, 873226. [Google Scholar] [CrossRef]
  32. ten Harkel, B.; Schoenmaker, T.; Picavet, D.I.; Davison, N.L.; de Vries, T.J.; Everts, V. The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts. PLoS ONE 2015, 10, e0139564. [Google Scholar] [CrossRef]
  33. Khan, U.A.; Hashimi, S.M.; Bakr, M.M.; Forwood, M.R.; Morrison, N.A. Foreign Body Giant Cells and Osteoclasts Are TRAP Positive, Have Podosome-Belts and Both Require OC-STAMP for Cell Fusion. J. Cell. Biochem. 2013, 114, 1772–1778. [Google Scholar] [CrossRef]
  34. Miron, R.J.; Zohdi, H.; Fujioka-Kobayashi, M.; Bosshardt, D.D. Giant Cells around Bone Biomaterials: Osteoclasts or Multi-Nucleated Giant Cells? Acta Biomater. 2016, 46, 15–28. [Google Scholar] [CrossRef]
  35. Jiranek, W.A.; Machado, M.; Jasty, M.; Jevsevar, D.; Wolfe, H.J.; Goldring, S.R.; Goldberg, M.J.; Harris, W.H. Production of Cytokines around Loosened Cemented Acetabular Components. Analysis with Immunohistochemical Techniques and in Situ Hybridization. J. Bone Jt. Surg. Am. 1993, 75, 863–879. [Google Scholar] [CrossRef]
  36. Hernandez-Pando, R.; Bornstein, Q.L.; Aguilar Leon, D.; Orozco, E.H.; Madrigal, V.K.; Martinez Cordero, E. Inflammatory Cytokine Production by Immunological and Foreign Body Multinucleated Giant Cells. Immunology 2000, 100, 352. [Google Scholar] [CrossRef]
  37. Jones, J.A.; Chang, D.T.; Meyerson, H.; Colton, E.; Il, K.K.; Matsuda, T.; Anderson, J.M. Proteomic Analysis and Quantification of Cytokines and Chemokines from Biomaterial Surface-Adherent Macrophages and Foreign Body Giant Cells. J. Biomed. Mater. Res. A 2007, 83, 585–596. [Google Scholar] [CrossRef]
  38. Sabokbar, A.; Pandey, R.; Quinn, J.M.; Athanasou, N.A. Osteoclastic Differentiation by Mononuclear Phagocytes Containing Biomaterial Particles. Arch. Orthop. Trauma Surg. 1998, 117, 136–140. [Google Scholar] [CrossRef]
  39. Pandey, R.; Quinn, J.; Joyner, C.; Murray, D.W.; Triffitt, J.T.; Athanasou, N.A. Arthroplasty Implant Biomaterial Particle Associated Macrophages Differentiate into Lacunar Bone Resorbing Cells. Ann. Rheum. Dis. 1996, 55, 388–395. [Google Scholar] [CrossRef]
  40. Morishita, K.; Tatsukawa, E.; Shibata, Y.; Suehiro, F.; Kamitakahara, M.; Yokoi, T.; Ioku, K.; Umeda, M.; Nishimura, M.; Ikeda, T. Diversity of Multinucleated Giant Cells by Microstructures of Hydroxyapatite and Plasma Components in Extraskeletal Implantation Model. Acta Biomater. 2016, 39, 180–191. [Google Scholar] [CrossRef]
  41. de Freitas Costa, N.; Melo, B.R.; Brito, R.T.; de Oliveira Fernandes, M.B.; Bernardo, V.G.; Fonseca, E.C.; Conz, M.B.; Soares, G.A.; Granjeiro, J.M. Quality and Intensity of the Tissue Response to Two Synthetic Granular Hydroxyapatite Implanted in Critical Defects of Rat Calvaria. Mater. Res. 2009, 12, 245–251. [Google Scholar] [CrossRef]
  42. Abels, M.; Alkildani, S.; Pröhl, A.; Xiong, X.; Krastev, R.; Korzinskas, T.; Stojanovic, S.; Jung, O.; Najman, S.; Barbeck, M. The Granule Size Mediates the In Vivo Foreign Body Response and the Integration Behavior of Bone Substitutes. Materials 2021, 14, 7372. [Google Scholar] [CrossRef] [PubMed]
  43. Herde, K.; Hartmann, S.; Brehm, R.; Kilian, O.; Heiss, C.; Hild, A.; Alt, V.; Bergmann, M.; Schnettler, R.; Wenisch, S. Connexin 43 Expression of Foreign Body Giant Cells after Implantation of Nanoparticulate Hydroxyapatite. Biomaterials 2007, 28, 4912–4921. [Google Scholar] [CrossRef] [PubMed]
  44. Sabokbar, A.; Pandey, R.; Díaz, J.; Quinn, J.M.; Murray, D.W.; Athanasou, N.A. Hydroxyapatite Particles Are Capable of Inducing Osteoclast Formation. J. Mater. Sci. Mater. Med. 2001, 12, 659–664. [Google Scholar] [CrossRef] [PubMed]
  45. Monchau, F.; Lefèvre, A.; Descamps, M.; Belquin-myrdycz, A.; Laffargue, P.; Hildebrand, H.F. In Vitro Studies of Human and Rat Osteoclast Activity on Hydroxyapatite, β-Tricalcium Phosphate, Calcium Carbonate. Biomol. Eng. 2002, 19, 143–152. [Google Scholar] [CrossRef]
  46. Nakamura, M.; Hentunen, T.; Salonen, J.; Nagai, A.; Yamashita, K. Characterization of Bone Mineral-Resembling Biomaterials for Optimizing Human Osteoclast Differentiation and Resorption. J. Biomed. Mater. Res. A 2013, 101, 3141–3151. [Google Scholar] [CrossRef]
  47. Yamada, S.; Heymann, D.; Bouler, J.M.; Daculsi, G. Osteoclastic Resorption of Calcium Phosphate Ceramics with Different Hydroxyapatite/β-Tricalcium Phosphate Ratios. Biomaterials 1997, 18, 1037–1041. [Google Scholar] [CrossRef]
  48. Doi, Y.; Iwanaga, H.; Shibutani, T.; Moriwaki, Y.; Iwayama, Y. Osteoclastic Responses to Various Calcium Phosphates in Cell Cultures. J. Biomed. Mater. Res. 1999, 47, 424–433. [Google Scholar] [CrossRef]
  49. Chen, F.; Wang, M.; Wang, J.; Chen, X.; Li, X.; Xiao, Y.; Zhang, X. Effects of Hydroxyapatite Surface Nano/Micro-Structure on Osteoclast Formation and Activity. J. Mater. Chem. B 2019, 7, 7574–7587. [Google Scholar] [CrossRef]
  50. Davison, N.L.; Su, J.; Yuan, H.; van den Beucken, J.J.J.P.; de Bruijn, J.D.; de Groot, F.B. Influence of Surface Microstructure and Chemistry on Osteoinduction and Osteoclastogenesis by Biphasic Calcium Phosphate Discs. Eur. Cell Mater. 2015, 29, 314–329. [Google Scholar] [CrossRef]
  51. Costa-Rodrigues, J.; Fernandes, A.; Lopes, M.A.; Fernandes, M.H. Hydroxyapatite Surface Roughness: Complex Modulation of the Osteoclastogenesis of Human Precursor Cells. Acta Biomater. 2012, 8, 1137–1145. [Google Scholar] [CrossRef]
  52. Costa, D.O.; Prowse, P.D.H.; Chrones, T.; Sims, S.M.; Hamilton, D.W.; Rizkalla, A.S.; Dixon, S.J. The Differential Regulation of Osteoblast and Osteoclast Activity by Surface Topography of Hydroxyapatite Coatings. Biomaterials 2013, 34, 7215–7226. [Google Scholar] [CrossRef]
  53. Gross, K.A.; Muller, D.; Lucas, H.; Haynes, D.R. Osteoclast Resorption of Thermal Spray Hydoxyapatite Coatings Is Influenced by Surface Topography. Acta Biomater. 2012, 8, 1948–1956. [Google Scholar] [CrossRef]
  54. Ciapetti, G.; di Pompo, G.; Avnet, S.; Martini, D.; Diez-Escudero, A.; Montufar, E.B.; Ginebra, M.P.; Baldini, N. Osteoclast Differentiation from Human Blood Precursors on Biomimetic Calcium-Phosphate Substrates. Acta Biomater. 2017, 50, 102–113. [Google Scholar] [CrossRef]
  55. He, Y.; Gao, Y.; Ma, Q.; Zhang, X.; Zhang, Y.; Song, W. Nanotopographical Cues for Regulation of Macrophages and Osteoclasts: Emerging Opportunities for Osseointegration. J. Nanobiotechnol. 2022, 20, 510. [Google Scholar] [CrossRef]
  56. Shiwaku, Y.; Neff, L.; Nagano, K.; Takeyama, K.I.; de Bruijn, J.; Dard, M.; Gori, F.; Baron, R. The Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the Composition and Structure of Biphasic Calcium Phosphates. PLoS ONE 2015, 10, e0132903. [Google Scholar] [CrossRef]
  57. Thevenot, P.; Hu, W.; Tang, L. Surface chemistry influence implant biocompatibility. Curr. Top. Med. Chem. 2008, 8, 270. [Google Scholar] [CrossRef]
  58. Zhu, Y.; Liang, H.; Liu, X.; Wu, J.; Yang, C.; Wong, T.M.; Kwan, K.Y.H.; Cheung, K.M.C.; Wu, S.; Yeung, K.W.K. Regulation of Macrophage Polarization through Surface Topography Design to Facilitate Implant-to-Bone Osteointegration. Sci. Adv. 2021, 7, eabf6654. [Google Scholar] [CrossRef]
  59. Chen, S.; Jones, J.A.; Xu, Y.; Low, H.Y.; Anderson, J.M.; Leong, K.W. Characterization of Topographical Effects on Macrophage Behavior in a Foreign Body Response Model. Biomaterials 2010, 31, 3479. [Google Scholar] [CrossRef]
  60. Robotti, F.; Bottan, S.; Fraschetti, F.; Mallone, A.; Pellegrini, G.; Lindenblatt, N.; Starck, C.; Falk, V.; Poulikakos, D.; Ferrari, A. A Micron-Scale Surface Topography Design Reducing Cell Adhesion to Implanted Materials. Sci. Rep. 2018, 8, 10887. [Google Scholar] [CrossRef]
  61. Bose, S.; Tarafder, S.; Bandyopadhyay, A. Hydroxyapatite Coatings for Metallic Implants. In Hydroxyapatite (Hap) for Biomedical Applications; Woodhead Publishing: Cambridge, UK, 2015; pp. 143–157. [Google Scholar]
  62. Faig-Martí, J.; Gil-Mur, F.J. Hydroxyapatite Coatings in Prosthetic Joints. Rev. Española Cirugía Ortopédica Traumatol. (Engl. Ed.) 2008, 52, 113–120. [Google Scholar] [CrossRef]
  63. Sun, L.; Berndt, C.C.; Gross, K.A.; Kucuk, A. Material Fundamentals and Clinical Performance of Plasma-Sprayed Hydroxyapatite Coatings: A Review. J. Biomed. Mater. Res. 2001, 58, 570–592. [Google Scholar] [CrossRef] [PubMed]
  64. Hashemi Astaneh, S.; Faverani, L.P.; Sukotjo, C.; Takoudis, C.G. Atomic Layer Deposition on Dental Materials: Processing Conditions and Surface Functionalization to Improve Physical, Chemical, and Clinical Properties—A Review. Acta Biomater. 2021, 121, 103–118. [Google Scholar] [CrossRef] [PubMed]
  65. Oviroh, P.O.; Akbarzadeh, R.; Pan, D.; Coetzee, R.A.M.; Jen, T.-C. New Development of Atomic Layer Deposition: Processes, Methods and Applications. Sci. Technol. Adv. Mater. 2019, 20, 465–496. [Google Scholar] [CrossRef]
  66. Holopainen, J.; Kauppinen, K.; Mizohata, K.; Santala, E.; Mikkola, E.; Heikkilä, M.; Kokkonen, H.; Leskelä, M.; Lehenkari, P.; Tuukkanen, J.; et al. Preparation and Bioactive Properties of Nanocrystalline Hydroxyapatite Thin Films Obtained by Conversion of Atomic Layer Deposited Calcium Carbonate. Biointerphases 2014, 9, 031008. [Google Scholar] [CrossRef]
  67. Avila, I.; Pantchev, K.; Holopainen, J.; Ritala, M.; Tuukkanen, J. Adhesion and Mechanical Properties of Nanocrystalline Hydroxyapatite Coating Obtained by Conversion of Atomic Layer-Deposited Calcium Carbonate on Titanium Substrate. J. Mater. Sci. Mater. Med. 2018, 29, 111. [Google Scholar] [CrossRef]
  68. Kylmäoja, E.; Holopainen, J.; Abushahba, F.; Ritala, M.; Tuukkanen, J. Osteoblast Attachment on Titanium Coated with Hydroxyapatite by Atomic Layer Deposition. Biomolecules 2022, 12, 654. [Google Scholar] [CrossRef]
  69. Kylmäoja, E.; Nakamura, M.; Turunen, S.; Patlaka, C.; Andersson, G.; Lehenkari, P.; Tuukkanen, J. Peripheral Blood Monocytes Show Increased Osteoclast Differentiation Potential Compared to Bone Marrow Monocytes. Heliyon 2018, 4, e00780. [Google Scholar] [CrossRef]
  70. Chappard, D.; Kün-Darbois, J.D.; Pascaretti-Grizon, F.; Camprasse, G.; Camprasse, S. Giant Cells and Osteoclasts Present in Bone Grafted with Nacre Differ by Nuclear Cytometry Evaluated by Texture Analysis. J. Mater. Sci. Mater. Med. 2019, 30, 1–7. [Google Scholar] [CrossRef]
  71. Redey, S.A.; Razzouk, S.; Rey, C.; Bernache-Assollant, D.; Leroy, G. Osteoclast Adhesion and Activity on Synthetic Hydroxyapatite, Carbonated Hydroxyapatite, and Natural Calcium Carbonate: Relationship to Surface Energies. J. Biomed. Mater. Res. 1999, 45, 140–147. [Google Scholar] [CrossRef]
  72. Al-Maawi, S.; Orlowska, A.; Sader, R.; James Kirkpatrick, C.; Ghanaati, S. In Vivo Cellular Reactions to Different Biomaterials—Physiological and Pathological Aspects and Their Consequences. Semin. Immunol. 2017, 29, 49–61. [Google Scholar] [CrossRef]
  73. Ghanaati, S.; Udeabor, S.E.; Barbeck, M.; Willershausen, I.; Kuenzel, O.; Sader, R.A.; Kirkpatrick, J. Implantation of Silicon Dioxide-Based Nanocrystalline Hydroxyapatite and Pure Phase Beta-Tricalciumphosphate Bone Substitute Granules in Caprine Muscle Tissue Does Not Induce New Bone Formation. Head Face Med. 2013, 9, 1. [Google Scholar] [CrossRef]
  74. Okuda, T.; Ioku, K.; Yonezawa, I.; Minagi, H.; Gonda, Y.; Kawachi, G.; Kamitakahara, M.; Shibata, Y.; Murayama, H.; Kurosawa, H.; et al. The Slow Resorption with Replacement by Bone of a Hydrothermally Synthesized Pure Calcium-Deficient Hydroxyapatite. Biomaterials 2008, 29, 2719–2728. [Google Scholar] [CrossRef]
  75. Brinkmann, J.; Hefti, T.; Schlottig, F.; Spencer, N.D.; Hall, H. Response of Osteoclasts to Titanium Surfaces with Increasing Surface Roughness: An in Vitro Study. Biointerphases 2012, 7, 34. [Google Scholar] [CrossRef]
  76. Makihira, S.; Mine, Y.; Kosaka, E.; Nikawa, H. Titanium Surface Roughness Accelerates RANKL-Dependent Differentiation in the Osteoclast Precursor Cell Line, RAW264.7. Dent. Mater. J. 2007, 26, 739–745. [Google Scholar] [CrossRef]
  77. Sommer, B.; Felix, R.; Sprecher, C.; Leunig, M.; Ganz, R.; Hofstetter, W. Wear Particles and Surface Topographies Are Modulators of Osteoclastogenesis in Vitro. J. Biomed. Mater. Res. A 2005, 72, 67–76. [Google Scholar] [CrossRef]
  78. Nagasawa, M.; Cooper, L.F.; Ogino, Y.; Mendonca, D.; Liang, R.; Yang, S.; Mendonca, G.; Uoshima, K. Topography Influences Adherent Cell Regulation of Osteoclastogenesis. J. Dent. Res. 2016, 95, 319–326. [Google Scholar] [CrossRef]
  79. Roy, M.; Bose, S. Osteoclastogenesis and Osteoclastic Resorption of Tricalcium Phosphate: Effect of Strontium and Magnesium Doping. J. Biomed. Mater. Res. A 2012, 100A, 2450–2461. [Google Scholar] [CrossRef]
  80. Gittens, R.A.; Scheideler, L.; Rupp, F.; Hyzy, S.L.; Geis-Gerstorfer, J.; Schwartz, Z.; Boyan, B.D. A Review on the Wettability of Dental Implant Surfaces II: Biological and Clinical Aspects. Acta Biomater. 2014, 10, 2907–2918. [Google Scholar] [CrossRef]
  81. Surmeneva, M.A.; Kleinhans, C.; Vacun, G.; Kluger, P.J.; Schönhaar, V.; Müller, M.; Hein, S.B.; Wittmar, A.; Ulbricht, M.; Prymak, O.; et al. Nano-Hydroxyapatite-Coated Metal-Ceramic Composite of Iron-Tricalcium Phosphate: Improving the Surface Wettability, Adhesion and Proliferation of Mesenchymal Stem Cells in Vitro. Colloids Surf. B Biointerfaces 2015, 135, 386–393. [Google Scholar] [CrossRef]
  82. Davison, N.L.; Luo, X.; Schoenmaker, T.; Everts, V.; Yuan, H.; Barrère-de Groot, F.; de Bruijn, J.D. Submicron-Scale Surface Architecture of Tricalcium Phosphate Directs Osteogenesis in Vitro and in Vivo. Eur. Cell Mater. 2014, 27, 281–297. [Google Scholar] [CrossRef] [PubMed]
  83. Davison, N.L.; ten Harkel, B.; Schoenmaker, T.; Luo, X.; Yuan, H.; Everts, V.; Barrère-de Groot, F.; de Bruijn, J.D. Osteoclast Resorption of Beta-Tricalcium Phosphate Controlled by Surface Architecture. Biomaterials 2014, 35, 7441–7451. [Google Scholar] [CrossRef] [PubMed]
  84. Zhang, J.; Luo, X.; Barbieri, D.; Barradas, A.M.C.; de Bruijn, J.D.; van Blitterswijk, C.A.; Yuan, H. The Size of Surface Microstructures as an Osteogenic Factor in Calcium Phosphate Ceramics. Acta Biomater. 2014, 10, 3254–3263. [Google Scholar] [CrossRef] [PubMed]
  85. Costa-Rodrigues, J.; Carmo, S.; Perpétuo, I.P.; Monteiro, F.J.; Fernandes, M.H. Osteoclastogenic Differentiation of Human Precursor Cells over Micro- and Nanostructured Hydroxyapatite Topography. Biochim. Biophys. Acta Gen. Subj. 2016, 1860, 825–835. [Google Scholar] [CrossRef]
  86. Mohammed Mohammed, A.H.; Shariff, K.A.; Bakar, M.H.A.; Mohamad, H. A Review on the Behavioral Responses of Osteoclast and Osteoblast Cells on the Near-Surface of the Bioceramic Coating: Roles of Ions Released, Solubility, and PH. J. Aust. Ceram. Soc. 2022, 58, 1715–1727. [Google Scholar] [CrossRef]
  87. Trindade, R.; Albrektsson, T.; Tengvall, P.; Wennerberg, A. Foreign Body Reaction to Biomaterials: On Mechanisms for Buildup and Breakdown of Osseointegration. Clin. Implant Dent. Relat. Res. 2014, 18, 192–203. [Google Scholar] [CrossRef]
  88. Smieszek, A.; Seweryn, A.; Marcinkowska, K.; Sikora, M.; Lawniczak-Jablonska, K.; Witkowski, B.S.; Kuzmiuk, P.; Godlewski, M.; Marycz, K. Titanium Dioxide Thin Films Obtained by Atomic Layer Deposition Promotes Osteoblasts’ Viability and Differentiation Potential While Inhibiting Osteoclast Activity—Potential Application for Osteoporotic Bone Regeneration. Materials 2020, 13, 4817. [Google Scholar] [CrossRef]
  89. Zvaifler, N.J.; Marinova-Mutafchieva, L.; Adams, G.; Edwards, C.J.; Moss, J.; Burger, J.A.; Maini, R.N. Mesenchymal Precursor Cells in the Blood of Normal Individuals. Arthritis Res. 2000, 2, 477–488. [Google Scholar] [CrossRef]
  90. Kassis, I.; Zangi, L.; Rivkin, R.; Levdansky, L.; Samuel, S.; Marx, G.; Gorodetsky, R. Isolation of Mesenchymal Stem Cells from G-CSF-Mobilized Human Peripheral Blood Using Fibrin Microbeads. Bone Marrow Transplant. 2006, 37, 967–976. [Google Scholar] [CrossRef]
  91. Karst, M.; Gorny, G.; Sells Galvin, R.J.; Oursler, M.J. Roles of Stromal Cell RANKL, OPG, and M-CSF Expression in Biphasic TGF-b Regulation of Osteoclast Differentiation. J. Cell. Physiol. 2004, 200, 99–106. [Google Scholar] [CrossRef]
  92. Sharaf-Eldin, W.E.; Abu-Shahba, N.; Mahmoud, M.; El-Badri, N. The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis. Stem Cells Int. 2016, 2016, 1908365. [Google Scholar] [CrossRef]
  93. Nilsen, O.; Fjellvåg, H.; Kjekshus, A. Growth of Calcium Carbonate by the Atomic Layer Chemical Vapour Deposition Technique. Thin Solid Film. 2004, 450, 240–247. [Google Scholar] [CrossRef]
  94. de Jong, H.P.; van Pelt, A.W.J.; Arends, J. Contact Angle Measurements on Human Enamel—An in Vitro Study of Influence of Pellicle and Storage Period. J. Dent. Res. 1982, 61, 11–13. [Google Scholar] [CrossRef]
  95. Susa, M.; Luong-Nguyen, N.H.; Cappellen, D.; Zamurovic, N.; Gamse, R. Human Primary Osteoclasts: In Vitro Generation and Applications as Pharmacological and Clinical Assay. J. Transl. Med. 2004, 2, 6. [Google Scholar] [CrossRef]
Figure 1. FESEM images of non-coated Ti sample (A,C) and ALD-HA (B,D). HA crystals appear on ALD-HA, whereas the non-coated Ti sample is devoid of them. Magnification 4000× (A,B) and 10,000× (C,D).
Figure 1. FESEM images of non-coated Ti sample (A,C) and ALD-HA (B,D). HA crystals appear on ALD-HA, whereas the non-coated Ti sample is devoid of them. Magnification 4000× (A,B) and 10,000× (C,D).
Molecules 28 03611 g001
Figure 2. Typical 3D surface profile of non-coated Ti, ALD-HA, and bovine bone slice samples. The surface profiles of non-coated Ti sample (A) and ALD-HA surface (B) demonstrated a lower surface roughness value compared to the bovine bone slice profile (C). Images were captured using a 5× objective lens and a 0.5 multiplier.
Figure 2. Typical 3D surface profile of non-coated Ti, ALD-HA, and bovine bone slice samples. The surface profiles of non-coated Ti sample (A) and ALD-HA surface (B) demonstrated a lower surface roughness value compared to the bovine bone slice profile (C). Images were captured using a 5× objective lens and a 0.5 multiplier.
Molecules 28 03611 g002
Figure 3. Confocal microscope (A,B) and FESEM (C) images of multinuclear cells and resorption on bone and ALD-HA. When stimulated with osteoclastogenic growth factors RANKL and M-CSF, peripheral blood monocytes differentiated into small multinuclear cells (arrowheads) with actin rings on bone (A), whereas on ALD-HA large multinuclear cells were generated (B). Bone resorption was evident on bone surface ((C); asterisks), and occasional small osteoclasts (arrowheads) were observed in or near the resorption pits. ALD-HA was devoid of resorption pits but was covered with large, flat multinuclear cells (arrowheads).
Figure 3. Confocal microscope (A,B) and FESEM (C) images of multinuclear cells and resorption on bone and ALD-HA. When stimulated with osteoclastogenic growth factors RANKL and M-CSF, peripheral blood monocytes differentiated into small multinuclear cells (arrowheads) with actin rings on bone (A), whereas on ALD-HA large multinuclear cells were generated (B). Bone resorption was evident on bone surface ((C); asterisks), and occasional small osteoclasts (arrowheads) were observed in or near the resorption pits. ALD-HA was devoid of resorption pits but was covered with large, flat multinuclear cells (arrowheads).
Molecules 28 03611 g003
Table 1. Mean and standard deviation of water contact angle and surface roughness determination on non-coated Ti sample, ALD-HA, and bovine bone slice. a p < 0.001, non-coated Ti sample vs. ALD-HA or bone; b p < 0.001, ALD-HA vs. bone.
Table 1. Mean and standard deviation of water contact angle and surface roughness determination on non-coated Ti sample, ALD-HA, and bovine bone slice. a p < 0.001, non-coated Ti sample vs. ALD-HA or bone; b p < 0.001, ALD-HA vs. bone.
Contact Angle (°),
Mean (SD)
Surface Roughness (Ra; µm),
Mean (SD)
Non-coated Ti sample86.9 (3.2)1.21 a (0.05)
ALD-HA86.2 (4.5)0.713 b (0.08)
Bone86.7 (4.5)2.30 (0.18)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kylmäoja, E.; Abushahba, F.; Holopainen, J.; Ritala, M.; Tuukkanen, J. Monocyte Differentiation on Atomic Layer-Deposited (ALD) Hydroxyapatite Coating on Titanium Substrate. Molecules 2023, 28, 3611. https://doi.org/10.3390/molecules28083611

AMA Style

Kylmäoja E, Abushahba F, Holopainen J, Ritala M, Tuukkanen J. Monocyte Differentiation on Atomic Layer-Deposited (ALD) Hydroxyapatite Coating on Titanium Substrate. Molecules. 2023; 28(8):3611. https://doi.org/10.3390/molecules28083611

Chicago/Turabian Style

Kylmäoja, Elina, Faleh Abushahba, Jani Holopainen, Mikko Ritala, and Juha Tuukkanen. 2023. "Monocyte Differentiation on Atomic Layer-Deposited (ALD) Hydroxyapatite Coating on Titanium Substrate" Molecules 28, no. 8: 3611. https://doi.org/10.3390/molecules28083611

Article Metrics

Back to TopTop